Passage Bio, Inc. SEC filings PASG
Passage Bio, Inc. has 442 filings in SEC EDGAR's recent list, going back to Sep 6, 2019. Its latest annual report, Form ARS, was filed on Apr 7, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 10, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 3, 2026 (material agreement, unregistered share sale). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | Oct 9, 2026 | — |
| 424B3 | Prospectus | Oct 9, 2026 | — |
| S-4/A | Filing | Oct 8, 2026 | — |
| S-4/A | Filing | Oct 5, 2026 | — |
| S-4/A | Filing | Sep 21, 2026 | — |
| S-4/A | S-4a | Sep 3, 2026 | — |
| 425 | Filing | Sep 3, 2026 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Sep 3, 2026 | Sep 2, 2026 |
| 10-Q | Quarterly report | Aug 10, 2026 | Jun 30, 2026 |
| 425 | Filing | Jul 22, 2026 | — |
| S-4 | Registration for a merger or exchange | Jul 21, 2026 | — |
| 425 | Filing | Jun 24, 2026 | — |
| 425 | Filing | Jun 24, 2026 | — |
| 8-K |
Current report
Material agreement, Agreement ended, Unregistered share sale, Change in control, Officer or director change, Regulation FD disclosure, Other events
|
Jun 24, 2026 | Jun 23, 2026 |
| 8-K |
Current report
Agreement ended
|
May 27, 2026 | May 21, 2026 |
| 8-K |
Current report
Shareholder vote results
|
May 26, 2026 | May 19, 2026 |
| 10-Q | Quarterly report | May 12, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Exit or restructuring costs
|
Apr 28, 2026 | Apr 28, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 20, 2026 | Apr 20, 2026 |
| ARS | Annual report to shareholders | Apr 7, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Apr 7, 2026 | — |
| DEF 14A | Proxy statement | Apr 7, 2026 | May 19, 2026 |
| 8-K |
Current report
Agreement ended
|
Mar 10, 2026 | Mar 4, 2026 |
| S-8 | Employee stock plan registration | Mar 4, 2026 | — |
| 10-K | Annual report | Mar 3, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Mar 3, 2026 | Mar 3, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Jan 12, 2026 | Jan 12, 2026 |
| 10-Q | Quarterly report | Nov 10, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 10, 2025 | Nov 10, 2025 |
| 8-K |
Current report
Officer or director change
|
Sep 18, 2025 | Sep 16, 2025 |
| 10-Q | Quarterly report | Aug 12, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 12, 2025 | Aug 12, 2025 |
| 8-K |
Current report
Other events
|
Jul 29, 2025 | Jul 28, 2025 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change, Other events
|
Jul 14, 2025 | Jul 10, 2025 |
| 8-K |
Current report
Other events
|
Jun 23, 2025 | Jun 23, 2025 |
| 8-K |
Current report
Shareholder vote results
|
May 30, 2025 | May 28, 2025 |
| 10-Q | Quarterly report | May 13, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 13, 2025 | May 13, 2025 |
| ARS | Annual report to shareholders | Apr 16, 2025 | Dec 31, 2024 |
| DEFA14A | Additional proxy material | Apr 16, 2025 | — |
| DEF 14A | Proxy statement | Apr 16, 2025 | May 28, 2025 |
| PRE 14A | Preliminary proxy statement | Apr 4, 2025 | May 28, 2025 |
| 424B5 | Prospectus supplement | Mar 5, 2025 | — |
| S-8 | Employee stock plan registration | Mar 5, 2025 | — |
| 10-K | Annual report | Mar 4, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Mar 4, 2025 | Mar 4, 2025 |
| 8-K |
Current report
Listing notice
|
Jan 31, 2025 | Jan 29, 2025 |
| 8-K |
Current report
Results of operations, Exit or restructuring costs, Impairment, Regulation FD disclosure, Other events
|
Jan 10, 2025 | Jan 8, 2025 |
| 10-Q | Quarterly report | Nov 13, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 13, 2024 | Nov 13, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 24, 2024 | Oct 24, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Sep 16, 2024 | Sep 16, 2024 |
| 8-K |
Current report
Officer or director change
|
Sep 10, 2024 | Sep 9, 2024 |
| 8-K |
Current report
Impairment
|
Sep 6, 2024 | Sep 4, 2024 |
| 10-Q | Quarterly report | Aug 8, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 8, 2024 | Aug 8, 2024 |
| 8-K |
Current report
Listing notice
|
Aug 2, 2024 | Aug 1, 2024 |
| 8-K |
Current report
Material agreement, Results of operations, Officer or director change, Regulation FD disclosure
|
Aug 1, 2024 | Jul 26, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jul 16, 2024 | Jul 16, 2024 |
| 8-K |
Current report
Shareholder vote results
|
May 22, 2024 | May 21, 2024 |
| 424B3 | Prospectus | May 14, 2024 | — |
| 10-Q | Quarterly report | May 14, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 14, 2024 | May 14, 2024 |
| EFFECT | Filing | Apr 16, 2024 | — |
| CORRESP | Letter to the SEC | Apr 12, 2024 | — |
| DEFA14A | Additional proxy material | Apr 9, 2024 | — |
| DEF 14A | Proxy statement | Apr 9, 2024 | May 24, 2024 |
| ARS | Annual report to shareholders | Apr 9, 2024 | Dec 31, 2023 |
| UPLOAD | Letter from the SEC | Mar 7, 2024 | — |
| S-8 | Employee stock plan registration | Mar 4, 2024 | — |
| S-3 | Shelf registration | Mar 4, 2024 | — |
| 10-K | Annual report | Mar 4, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Results of operations, Officer or director change, Regulation FD disclosure
|
Mar 4, 2024 | Mar 4, 2024 |
| 8-K |
Current report
Other events
|
Feb 29, 2024 | Feb 29, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 5, 2024 | Jan 5, 2024 |
| 8-K |
Current report
Other events
|
Dec 29, 2023 | Dec 27, 2023 |
| 8-K |
Current report
Other events
|
Dec 20, 2023 | Dec 20, 2023 |
| 10-Q | Quarterly report | Nov 13, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 13, 2023 | Nov 13, 2023 |
| 8-K |
Current report
Listing notice
|
Sep 1, 2023 | Aug 31, 2023 |
| 10-Q | Quarterly report | Aug 7, 2023 | Jun 30, 2023 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure, Other events
|
Aug 7, 2023 | Aug 7, 2023 |
| 8-K |
Current report
Officer or director change
|
Jul 31, 2023 | Jul 26, 2023 |
| 8-K |
Current report
Officer or director change, Other events
|
Jul 20, 2023 | Jul 15, 2023 |
| 8-K |
Current report
Shareholder vote results
|
May 26, 2023 | May 25, 2023 |
| 10-Q | Quarterly report | May 11, 2023 | Mar 31, 2023 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 11, 2023 | May 11, 2023 |
| ARS | Annual report to shareholders | Apr 14, 2023 | Dec 31, 2022 |
| DEFA14A | Additional proxy material | Apr 14, 2023 | — |
| DEF 14A | Proxy statement | Apr 14, 2023 | May 25, 2023 |
| 8-K |
Current report
Material agreement
|
Apr 6, 2023 | Mar 31, 2023 |
| PRE 14A | Preliminary proxy statement | Apr 3, 2023 | May 25, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 10, 2023 | Mar 10, 2023 |
| S-8 | Employee stock plan registration | Mar 6, 2023 | — |
| 10-K | Annual report | Mar 6, 2023 | Dec 31, 2022 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Mar 6, 2023 | Mar 6, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Feb 24, 2023 | Feb 24, 2023 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Jan 9, 2023 | Jan 9, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 14, 2022 | Dec 14, 2022 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Dec 2, 2022 | Dec 1, 2022 |
| 10-Q | Quarterly report | Nov 10, 2022 | Sep 30, 2022 |
| 8-K |
Current report
Results of operations, Officer or director change, Regulation FD disclosure
|
Nov 10, 2022 | Nov 8, 2022 |
| 8-K |
Current report
Officer or director change
|
Oct 11, 2022 | Oct 10, 2022 |
| 8-K |
Current report
Other events
|
Aug 11, 2022 | Aug 11, 2022 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 4, 2022 | Aug 4, 2022 |
| 10-Q | Quarterly report | Aug 4, 2022 | Jun 30, 2022 |
| 8-K |
Current report
Officer or director change
|
Jul 6, 2022 | Jul 2, 2022 |
| 8-K |
Current report
Other events
|
Jun 8, 2022 | Jun 8, 2022 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 1, 2022 | May 26, 2022 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
May 18, 2022 | May 18, 2022 |
| 10-Q | Quarterly report | May 16, 2022 | Mar 31, 2022 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 16, 2022 | May 16, 2022 |
| EFFECT | Filing | Apr 14, 2022 | — |
| DEFA14A | Additional proxy material | Apr 14, 2022 | — |
| DEF 14A | Proxy statement | Apr 14, 2022 | May 26, 2022 |
| 8-K |
Current report
Other events
|
Mar 15, 2022 | Mar 15, 2022 |
| 8-K |
Current report
Officer or director change
|
Mar 11, 2022 | Mar 7, 2022 |
| 8-K |
Current report
Other events
|
Mar 10, 2022 | Mar 10, 2022 |
| POS AM | Filing | Mar 3, 2022 | — |
| S-8 | Employee stock plan registration | Mar 3, 2022 | — |
| POS AM | Filing | Mar 3, 2022 | — |
| 10-K | Annual report | Mar 3, 2022 | Dec 31, 2021 |
| 8-K |
Current report
Results of operations
|
Mar 3, 2022 | Mar 3, 2022 |
| POSASR | Filing | Mar 3, 2022 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Feb 11, 2022 | Feb 11, 2022 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure, Other events
|
Jan 10, 2022 | Jan 10, 2022 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Dec 17, 2021 | Dec 17, 2021 |
| 10-Q | Quarterly report | Nov 4, 2021 | Sep 30, 2021 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 4, 2021 | Nov 4, 2021 |
| 8-K |
Current report
Officer or director change
|
Nov 1, 2021 | Oct 26, 2021 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 4, 2021 | Oct 4, 2021 |
| 10-Q | Quarterly report | Aug 5, 2021 | Jun 30, 2021 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 5, 2021 | Aug 5, 2021 |
| 8-K |
Current report
Officer or director change
|
Jul 21, 2021 | Jul 15, 2021 |
| S-8 | Employee stock plan registration | Jul 19, 2021 | — |
| 8-K |
Current report
Shareholder vote results
|
May 28, 2021 | May 27, 2021 |
| 8-K |
Current report
Officer or director change
|
May 18, 2021 | May 14, 2021 |
| 10-Q | Quarterly report | May 5, 2021 | Mar 31, 2021 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 5, 2021 | May 5, 2021 |
| DEFA14A | Additional proxy material | Apr 14, 2021 | — |
| DEF 14A | Proxy statement | Apr 14, 2021 | May 27, 2021 |
| 8-K |
Current report
Officer or director change, Other events
|
Mar 22, 2021 | Mar 22, 2021 |
| S-3ASR | Automatic shelf registration | Mar 5, 2021 | — |
| S-8 | Employee stock plan registration | Mar 5, 2021 | — |
| 10-K | Annual report | Mar 3, 2021 | Dec 31, 2020 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Mar 3, 2021 | Mar 3, 2021 |
| 8-K |
Current report
Officer or director change
|
Feb 19, 2021 | Feb 18, 2021 |
| 8-K |
Current report
Officer or director change
|
Feb 17, 2021 | Feb 10, 2021 |
| 424B1 | Filing | Jan 22, 2021 | — |
| EFFECT | Filing | Jan 21, 2021 | — |
| CORRESP | Letter to the SEC | Jan 19, 2021 | — |
| CORRESP | Letter to the SEC | Jan 19, 2021 | — |
| S-1 | Registration statement | Jan 19, 2021 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 11, 2021 | Jan 11, 2021 |
| UPLOAD | Letter from the SEC | Dec 22, 2020 | — |
| DRS | Filing | Dec 18, 2020 | — |
| 8-K |
Current report
Material agreement
|
Dec 18, 2020 | Dec 15, 2020 |
| 10-Q | Quarterly report | Nov 10, 2020 | Sep 30, 2020 |
| 8-K |
Current report
Results of operations
|
Nov 10, 2020 | Nov 10, 2020 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 9, 2020 | Sep 9, 2020 |
| 10-Q | Quarterly report | Aug 13, 2020 | Jun 30, 2020 |
| 8-K |
Current report
Results of operations
|
Aug 13, 2020 | Aug 13, 2020 |
| 10-Q | Quarterly report | May 11, 2020 | Mar 31, 2020 |
| 8-K |
Current report
Results of operations
|
May 11, 2020 | May 11, 2020 |
| 8-K |
Current report
Material agreement
|
May 7, 2020 | May 5, 2020 |
| 8-K |
Current report
Material agreement
|
Apr 14, 2020 | Apr 10, 2020 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Apr 3, 2020 | Apr 3, 2020 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Mar 27, 2020 | Mar 26, 2020 |
| 424B4 | Prospectus | Feb 28, 2020 | — |
| S-8 | Employee stock plan registration | Feb 28, 2020 | — |
| EFFECT | Filing | Feb 27, 2020 | — |
| S-1MEF | Filing | Feb 27, 2020 | — |
| S-1/A | Amended registration statement | Feb 27, 2020 | — |
| SEC STAFF LETTER | Filing | Feb 26, 2020 | — |
| CORRESP | Letter to the SEC | Feb 25, 2020 | — |
| CORRESP | Letter to the SEC | Feb 25, 2020 | — |
| CERT | Filing | Feb 25, 2020 | — |
| FWP | Free writing prospectus | Feb 20, 2020 | — |
| 8-A12B | Filing | Feb 18, 2020 | — |
| S-1/A | Amended registration statement | Feb 18, 2020 | — |
| CORRESP | Letter to the SEC | Feb 7, 2020 | — |
| S-1 | Registration statement | Feb 3, 2020 | — |
| SEC STAFF LETTER | Filing | Jan 31, 2020 | — |
| SEC STAFF LETTER | Filing | Jan 17, 2020 | — |
| DRSLTR | Filing | Jan 10, 2020 | — |
| DRS/A | Filing | Jan 10, 2020 | — |
| UPLOAD | Letter from the SEC | Jan 3, 2020 | — |
| DRS | Filing | Dec 6, 2019 | — |
| D | Filing | Sep 6, 2019 | — |
Showing 189 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- PASG (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Philadelphia, PA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1787297
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.